Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R21)
The summary for the Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R21) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R21): -Purpose. The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA) and the National Institute of Neurological Disorders and Stroke (NINDS) is to issue a Request for Applications (RFA) to investigate CNS changes that occur with chronic pain and how these changes parallel those that occur with drug addiction. Of interest will be how chronic pain changes the CNS, how analgesics of various classes impact pain-induced CNS changes, and how analgesics in the absence of pain (some of which have abuse potential) produce CNS changes. The temporal course of these changes will also be of interest.A focus of this research will be comparing and contrasting these CNS changes in an effort to identify shared and unique mechanisms involved in pain, analgesia and drug abuse, as well as environmental and genetic factors that influence these changes. -Mechanism of Support. This FOA will utilize the R21 grant mechanism and runs in parallel with two FOAs of identical scientific scope, RFA-DA-09-017 (http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-09-017) and RFA-DA-09-019 (http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-09-019), that solicit applications under the R01 and R03 mechanisms, respectively. -Funds Available and Anticipated Number of Awards. The NIDA has set aside $2,000,000 to fund an anticipated 6-10 grant applications and the NINDS has set aside $375,000 to fund an anticipated two grants for this FOA and its companion R01 and R03.
Federal Grant Title: | Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R21) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-DA-09-018 |
Type of Funding: | Grant |
CFDA Numbers: | 93.279 |
CFDA Descriptions: | Drug Abuse and Addiction Research Programs |
Current Application Deadline: | Jan 28, 2009 |
Original Application Deadline: | Jan 28, 2009 |
Posted Date: | Oct 30, 2008 |
Creation Date: | Oct 30, 2008 |
Archive Date: | Feb 28, 2009 |
Total Program Funding: | $2,375,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
- • Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...
- • Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...
- • Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - C...
- • Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trials Not ...
- • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
- • Drug Abuse Aspects of Hiv/Aids and Other Infections
- • Epidemiology of Drug Abuse
- More Grants from the National Institutes of Health
- • Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical ...
- • Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Mino...
- • Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...
- • NINDS Program Project Grant (P01 Clinical Trial Optional)
- • Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial N...